An audit on the management of hypomagnesaemia on the wards in a district general hospital in the UK
1 Department of Diabetes and Endocrinology, Royal Albert Edward Infirmary, Wigan, WN1 2NN, UK.
2 Department of Medicine, Southport and Formby District General Hospital, Southport, PR8 6PN, UK.
Review
World Journal of Biology Pharmacy and Health Sciences, 2023, 14(02), 007–014.
Article DOI: 10.30574/wjbphs.2023.14.2.0203
Publication history:
Received on 23 March 2023; revised on 01 May 2023; accepted on 04 May 2023
Abstract:
Hypomagnesaemia (Low serum magnesium) can be a life- threatening condition, if severe, and can co-exist with hypokalaemia and hypocalcaemia (with hypoparathyroidism), though the serum magnesium level is not routinely estimated. Given the fact that many medications commonly used in clinical practice can lower the level of serum magnesium (along with other causes) by various mechanisms and that repletion of serum magnesium is absolutely necessary before correction of hypokalaemia and hypocalcaemia, in case of co-existence, we decided to do a short audit for 3 weeks in the month of January 2023, to get an understanding whether patients with hypomagnesaemia were managed adequately on the Wards, in accordance with the prevailing Guidelines. The findings showed that though the aetiology of low serum magnesium was not established in every case, symptomatic management of the condition was adequate.
Keywords:
Hypomagnesaemia; Hypokalaemia; Hypocalcaemia; Hypoparathyroidism; Guidelines
Full text article in PDF:
Copyright information:
Copyright © 2023 Author(s) retain the copyright of this article. This article is published under the terms of the Creative Commons Attribution Liscense 4.0